Search Results 2781-2790 of 18334 for rheumatoid arthritis
The mechanism of PEP-enhancing healing is to release bioactive transforming growth factor beta (TGF-β) into the wound bed. Sustained delivery through fibrin ...
... Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the Department of Defense (DOD), Regenerative Medicine Minnesota, and others. Dr. Zhao's current ...
Any known factor or disease that might interfere with treatment compliance, study conduct or interpretation of the results such as drug or alcohol ...
... factor treatment (e.g., erythropoietin), hormones (e.g., androgens, danazol) ≤ 14 days prior to registration; note: patients who are on ruxolitinib may ...
Departments that treat this condition · Kidney Transplant Program · Lupus Clinic · Physical Medicine and Rehabilitation · Rheumatology · Transplant Center · Women's ...
Posterior lumbar decompression and posterior lumbar fusion. Operative time was the most important risk factor for unplanned ROR , followed by patient ...
... factor receptor 2 (HER2) status and radiographic evidence of distant metastatic disease; Measurable disease; Head and neck cancer OR metastatic breast for ...
... factor (GM-CSF). Overall response rate was also higher in the talimogene laherparepvec arm, and the greatest efficacy was demonstrated in patients with ...
Orthopedic, joint degeneration (i.e., arthritis, self-reported) affecting the hand or cervical spine that severely limit upper limb function (observed).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.